Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera

Infection and Immunity

Volumn 77, Issue 1, 2009, Pages 472-484

  Schild, Stefan ^a,b   Nelson, Eric J ^a   Bishop, Anne L ^a   Camilli, Andrew ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CHOLERA VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; OUTER MEMBRANE VESICLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BACTERIAL COLONIZATION; BREAST MILK; CHOLERA; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MEMBRANE VESICLE; MOUSE; NEWBORN; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; STOMACH CONTENT; VIBRIO CHOLERAE;

EID: 58449103058     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01139-08     Document Type: Article

References (65)

1. Ahouse, J. J., C. L. Hagerman, P. Mittal, D. J. Gilbert, N. G. Copeland, N. A. Jenkins, and N. E. Simister. 1993. Mouse MHC class I-like Fc receptor encoded outside the MHC. J. Immunol. 151:6076-6088.
2. Alaniz, R. C., B. L. Deatherage, J. C. Lara, and B. T. Cookson. 2007. Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. J. Immunol. 179:7692-7701.
3. Appleby, P., and D. Catty. 1983. Transmission of immunoglobulin to foetal and neonatal mice. J. Reprod. Immunol. 5:203-213.
4. Bennish, M. L. 1994. Cholera: pathophysiology, clinical features, and treatment, p. 229-255. In K. I. Wachsmuth, P. A. Blake, and O. Olsik (ed.), Vibrio cholerae and cholera: molecular to global perspectives. ASM Press, Washington, DC.
5. Bradford, A. K., A. B. Cheryl, and J. G. Wells. 1994. Isolation and identification of Vibrio cholerae O1 from fecal specimens, p. 3-25. In K. Wachsmut, P. A. Blake, and O. Olsvik (ed.), Vibrio cholerae and cholera: molecular to global perspectives. ASM Press, Washington, DC.
6. Brandtzaeg, P. 2003. Mucosal immunity: integration between mother and the breast-fed infant. Vaccine 21:3382-3388.
7. Butterton, J. R., E. T. Ryan, R. A. Shahin, and S. B. Calderwood. 1996. Development of a germfree mouse model of Vibrio cholerae infection. Infect. Immun. 64:4373-4377.
8. Camilli, A., D. T. Beattie, and J. J. Mekalanos. 1994. Use of genetic recombination as a reporter of gene expression. Proc. Natl. Acad. Sci. USA 91: 2634-2638.
9. Carretti, N., and Z. Ovary. 1969. Transmission of gamma G antibodies from maternal to fetal circulation in the mouse. Proc. Soc Exp. Biol. Med. 130: 509-512.
10. Chatterjee, S. N., and K. Chaudhuri. 2003. Lipopolysaccharides of Vibrio cholerae. I. Physical and chemical characterization. Biochim. Biophys. Acta 1639:65-79.
11. Clemens, J. D., D. A. Sack, J. R. Harris, M. R. Khan, J. Chakraborty, S. Chowdhury, M. R. Rao, F. P. van Loon, B. F. Stanton, M. Yunus, et al. 1990. Breast feeding and the risk of severe cholera in rural Bangladeshi children. Am. J. Epidemiol. 131:400-411.
12. Dalseg, R., E. Wedege, J. Holst, I. L. Haugen, E. A. Hoiby, and B. Haneberg. 1999. Outer membrane vesicles from group B meningococci are strongly immunogenic when given intranasally to mice. Vaccine 17:2336-2345.
13. Fahey, J. L., and W. F. Barth. 1965. The immunoglobulins of mice. 4. Serum immunoglobulin changes following birth. Proc. Soc. Exp. Biol. Med. 118: 596-600.
14. Faruque, S. M., M. J. Albert, and J. J. Mekalanos. 1998. Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae. Microbiol. Mol. Biol. Rev. 62:1301-1314.
15. Fisseha, M., P. Chen, B. Brandt, T. Kijek, E. Moran, and W. Zollinger. 2005. Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination. Infect. Immun. 73:4070-4080.
16. Fredriksen, J. H., E. Rosenqvist, E. Wedege, K. Bryn, G. Bjune, L. O. Froholm, A. K. Lindbak, B. Mogster, E. Namork, U. Rye, et al.1991. Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease. NIPH Ann. 14:67-80.
17. Glass, R. I., A. M. Svennerholm, B. J. Stoll, M. R. Khan, K. M. Hossain, M. I. Huq, and J. Holmgren. 1983. Protection against cholera in breast-fed children by antibodies in breast milk. N. Engl. J. Med. 308:1389-1392.
18. Guentzel, M. N., and L. J. Berry. 1974. Protection of suckling mice from experimental cholera by maternal immunization: comparison of the efficacy of whole-cell, ribosomal-derived, and enterotoxin immunogens. Infect. Immun. 10:167-172.
19. Haneberg, B., R. Dalseg, F. Oftung, E. Wedege, E. A. Hoiby, I. L. Haugen, J. Holst, S. R. Andersen, A. Aase, L. Meyer Naess, T. E. Michaelsen, E. Namork, and L. R. Haaheim. 1998. Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvant. Dev. Biol. Stand. 92:127-133.
20. Haneberg, B., R. Dalseg, E. Wedege, E. A. Hoiby, I. L. Haugen, F. Oftung, S. R. Andersen, L. M. Naess, A. Aase, T. E. Michaelsen, and J. Holst. 1998. Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans. Infect. Immun. 66:1334-1341.
21. Hanson, L. A., S. Ahlstedt, B. Andersson, B. Carlsson, M. F. Cole, J. R. Cruz, U. Dahlgren, T. H. Ericsson, F. Jalil, S. R. Khan, L. Mellander, R. Schneerson, C. S. Eden, T. Soderstrom, and C. Wadsworth. 1983. Mucosal immunity. Ann. N. Y. Acad. Sci. 409:1-21.
22. Hanson, L. A., S. Ahlstedt, B. Carlsson, S. P. Fallstrom, B. Kaijser, B. S. Lindblad, A. S. Akerlund, and C. S. Eden. 1978. New knowledge in human milk immunoglobulin. Acta Paediatr. Scand. 67:577-582.
23. Hanson, L. A., Y. Hofvander, B. Lindquist, and R. Zetterstrom. 1985. Breastfeeding as a protection against gastroenteritis and other infections. Acta Paediatr. Scand. 74:641-642.
24. Harris, J. B., R. C. Larocque, F. Chowdhury, A. I. Khan, T. Logvinenko, A. S. Faruque, E. T. Ryan, F. Qadri, and S. B. Calderwood. 2008. Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh. PLoS Negl. Trop. Dis. 2:e221.
25. Jertborn, M., A. M. Svennerholm, and J. Holmgren. 1993. Evaluation of different immunization schedules for oral cholera B subunit-whole cell vaccine in Swedish volunteers. Vaccine 11:1007-1012.
26. Jertborn, M., A. M. Svennerholm, and J. Holmgren. 1994. Immunological memory after immunization with oral cholera B subunit-whole-cell vaccine in Swedish volunteers. Vaccine 12:1078-1082.
27. Jertborn, M., A. M. Svennerholm, and J. Holmgren. 1992. Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers. Vaccine 10:130-132.
28. Jones, E. A., and T. A. Waldmann. 1972. The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat. J. Clin. Investig. 51:2916-2927.
29. Kaper, J., H. Lockman, R. R. Colwell, and S. W. Joseph. 1979. Ecology, serology, and enterotoxin production of Vibrio cholerae in Chesapeake Bay. Appl. Environ. Microbiol. 37:91-103.
30. Kaper, J. B., J. G. Morris, Jr., and M. M. Levine. 1995. Cholera. Clin. Microbiol. Rev. 8:48-86.
31. Keenan, J., T. Day, S. Neal, B. Cook, G. Perez-Perez, R. Allardyce, and P. Bagshaw. 2000. A role for the bacterial outer membrane in the pathogenesis of Helicobacter pylori infection. FEMS Microbiol. Lett. 182:259-264.
32. Kenne, L., B. Lindberg, P. Unger, B. Gustafsson, and T. Holme. 1982. Structural studies of the Vibrio cholerae O-antigen. Carbohydr. Res. 100:341-349.
33. Kesavalu, L., J. L. Ebersole, R. L. Machen, and S. C. Holt. 1992. Porphyromonas gingivalis virulence in mice: induction of immunity to bacterial components. Infect. Immun. 60:1455-1464.
34. Kesty, N. C., and M. J. Kuehn. 2004. Incorporation of heterologous outer membrane and periplasmic proteins into Escherichia coli outer membrane vesicles. J. Biol. Chem. 279:2069-2076.
35. Kim, J. Y., A. M. Doody, D. J. Chen, G. H. Cremona, M. L. Shuler, D. Putnam, and M. P. Delisa. 2008. Engineered bacterial outer membrane vesicles with enhanced functionality. J. Mol. Biol. 380:51-66.
36. Klose, K. E. 2000. The suckling mouse model of cholera. Trends Microbiol. 8:189-191.
37. Knirel, Y. A., G. Widmalm, S. N. Senchenkova, P.-E. Jansson, and A. Weintraub. 1997. Structural studies on the short-chain lipopolysaccharide of Vibrio cholerae O139 Bengal. Eur. J. Biochem. 247:402-410.
38. Koch, R. 1884. An address on cholera and its bacillus. Br. Med. J. ii(1235): 403-407.
39. Kondo, K., A. Takade, and K. Amako. 1993. Release of the outer membrane vesicles from Vibrio cholerae and Vibrio parahaemolyticus. Microbiol. Immunol. 37:149-152.
40. Manoil, C., and J. Beckwith. 1985. TnphoA: a transposon probe for protein export signals. Proc. Natl. Acad. Sci. USA 82:8129-8133.
41. Martin, D. R., S. J. Walker, M. G. Baker, and D. R. Lennon. 1998. New Zealand epidemic of meningococcal disease identified by a strain with phenotype B:4:P1.4. J. Infect. Dis. 177:497-500.
42. Merrell, D. S., and A. Camilli. 2000. Regulation of Vibrio cholerae genes required for acid tolerance by a member of the "ToxR-like" family of transcriptional regulators. J. Bacteriol. 182:5342-5350.
43. Miller, V. L., V. J. DiRita, and J. J. Mekalanos. 1989. Identification of toxS, a regulatory gene whose product enhances toxR-mediated activation of the cholera toxin promoter. J. Bacteriol. 171:1288-1293.
44. O'Dwyer, C., A., K. Reddin, D. Martin, S. C. Taylor, A. R. Gorringe, M. J. Hudson, B. R. Brodeur, P. R. Langford, and J. S. Kroll. 2004. Expression of heterologous antigens in commensal Neisseria spp.: preservation of conformational epitopes with vaccine potential. Infect. Immun. 72:6511-6518.
45. Olivier, V., N. H. Salzman, and K. J. Satchell. 2007. Prolonged colonization of mice by Vibrio cholerae El Tor O1 depends on accessory toxins. Infect. Immun. 75:5043-5051.
46. Peterson, K. M., and J. J. Mekalanos. 1988. Characterization of the Vibrio cholerae ToxR regulon: identification of novel genes involved in intestinal colonization. Infect. Immun. 56:2822-2829.
47. Qureshi, K., K. Molbak, A. Sandstrom, P. E. Kofoed, A. Rodrigues, F. Dias, P. Aaby, and A. M. Svennerholm. 2006. Breast milk reduces the risk of illness in children of mothers with cholera: observations from an epidemic of cholera in Guinea-Bissau. Pediatr. Infect. Dis. J. 25:1163-1166.
48. Reidl, J., and K. E. Klose. 2002. Vibrio cholerae and cholera: out of the water and into the host. FEMS Microbiol. Rev. 26:125-139.
49. Roberts, D. M., M. Guenthert, and R. Rodewald. 1990. Isolation and characterization of the Fc receptor from the fetal yolk sac of the rat. J. Cell Biol. 111:1867-1876.
50. Rodewald, R., and J. P. Kraehenbuhl.1984. Receptor-mediated transport of IgG. J. Cell Biol. 99:159s-164s.
51. Sack, D. A., R. B. Sack, and C. L. Chaignat. 2006. Getting serious about cholera. N. Engl. J. Med. 355:649-651.
52. Sack, D. A., R. B. Sack, G. B. Nair, and A. K. Siddique.2004. Cholera. Lancet 363:223-233.
53. Saunders, N. B., D. R. Shoemaker, B. L. Brandt, E. E. Moran, T. Larsen, and W. D. Zollinger. 1999. Immunogenicity of intranasally administered meningococcal native outer membrane vesicles in mice. Infect. Immun. 67:113-119.
54. Schild, S., E. J. Nelson, and A. Camilli. 2008. Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice. Infect. Immun. 76:4554-4563.
55. Simister, N. E., and K. E. Mostov. 1989. An Fc receptor structurally related to MHC class I antigens. Nature 337:184-187.
56. Simister, N. E., and A. R. Rees. 1985. Isolation and characterization of an Fc receptor from neonatal rat small intestine. Eur. J. Immunol. 15:733-738.
57. Tacket, C. O., G. Losonsky, J. P. Nataro, L. Comstock, J. Michalski, R. Edelman, J. B. Kaper, and M. M. Levine. 1995. Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge. J. Infect. Dis. 172:883-886.
58. Taylor, R. K., V. L. Miller, D. B. Furlong, and J. J. Mekalanos. 1987. Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. Proc. Natl. Acad. Sci. USA 84:2833-2837.
59. Ujiye, A., and K. Kobari. 1970. Protective effect on infections with Vibrio cholerae in suckling mice caused by the passive immunization with milk of immune mothers. J. Infect. Dis. 121(Suppl. 121):50.
60. Vance, R. E., J. Zhu, and J. J. Mekalanos. 2003. A constitutively active variant of the quorum-sensing regulator LuxO affects protease production and biofilm formation in Vibrio cholerae. Infect. Immun. 71:2571-2576.
61. Van de Perre, P. 2003. Transfer of antibody via mother's milk. Vaccine 21:3374-3376.
62. Wallace, K. H., and A. R. Rees. 1980. Studies on the immunoglobulin-G Fc-fragment receptor from neonatal rat small intestine. Biochem. J. 188:9-16.
63. WHO. 2006. Global advisory committee on vaccine safety, 6-7 June 2006. Wkly. Epidemiol. Rec. 81:273-278. http://www.who.int/wer/2006/ wer8128.pdf.
64. Winner, L., III, J. Mack, R. Weltzin, J. J. Mekalanos, J. P. Kraehenbuhl, and M. R. Neutra. 1991. New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection. Infect. Immun. 59:977-982.
65. Yoshiyama, Y., and W. R. Brown. 1987. Specific antibodies to cholera toxin in rabbit milk are protective against Vibrio cholerae-induced intestinal secretion. Immunology 61:543-547.